» Articles » PMID: 31876447

Proteinase K Resistant Cores of Prions and Amyloids

Overview
Journal Prion
Specialty Biochemistry
Date 2019 Dec 27
PMID 31876447
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloids and their infectious subset, prions, represent fibrillary aggregates with regular structure. They are formed by proteins that are soluble in their normal state. In amyloid form, all or part of the polypeptide sequence of the protein is resistant to treatment with proteinase K (PK). Amyloids can have structural variants, which can be distinguished by the patterns of their digestion by PK. In this review, we describe and compare studies of the resistant cores of various amyloids from different organisms. These data provide insight into the fine structure of amyloids and their variants as well as raise interesting questions, such as those concerning the differences between amyloids obtained and , as well as the manner in which folding of one region of the amyloid can affect other regions.

Citing Articles

Refining α-synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophy.

Wiseman J, Turner C, Faull R, Halliday G, Dieriks B Transl Neurodegener. 2025; 14(1):7.

PMID: 39920796 PMC: 11804046. DOI: 10.1186/s40035-025-00469-6.


An accelerated Parkinson's disease monkey model using AAV-α-synuclein plus poly(ADP-ribose).

Liu S, Yang N, Yan Y, Wang S, Chen J, Wang Y Cell Rep Methods. 2024; 4(10):100876.

PMID: 39413778 PMC: 11573744. DOI: 10.1016/j.crmeth.2024.100876.


The thermodynamics of neurodegenerative disease.

Meisl G Biophys Rev (Melville). 2024; 5(1):011303.

PMID: 38525484 PMC: 10957229. DOI: 10.1063/5.0180899.


DRGD-linked charged EKKE dimeric dodecapeptide: pH-based amyloid nanostructures and their application in lead and uranium binding.

Natarajan A, Vadrevu L, Rangan K RSC Adv. 2024; 14(13):9200-9217.

PMID: 38505393 PMC: 10949120. DOI: 10.1039/d3ra08261j.


Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation.

Arar S, Haque M, Bhatt N, Zhao Y, Kayed R ACS Chem Neurosci. 2024; 15(7):1366-1377.

PMID: 38503425 PMC: 10995947. DOI: 10.1021/acschemneuro.3c00614.


References
1.
Masison D, Maddelein M, Wickner R . The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation. Proc Natl Acad Sci U S A. 1997; 94(23):12503-8. PMC: 25018. DOI: 10.1073/pnas.94.23.12503. View

2.
Kajava A, Baxa U, Wickner R, Steven A . A model for Ure2p prion filaments and other amyloids: the parallel superpleated beta-structure. Proc Natl Acad Sci U S A. 2004; 101(21):7885-90. PMC: 419526. DOI: 10.1073/pnas.0402427101. View

3.
Tuite M . Genetics. Psi no more for yeast prions. Nature. 1994; 370(6488):327-8. DOI: 10.1038/370327a0. View

4.
Parchi P, Chen S, Brown P, Zou W, Capellari S, Budka H . Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A. 1998; 95(14):8322-7. PMC: 20974. DOI: 10.1073/pnas.95.14.8322. View

5.
Krishnan R, Lindquist S . Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature. 2005; 435(7043):765-72. PMC: 1405905. DOI: 10.1038/nature03679. View